{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T04:40:11Z","timestamp":1748407211143,"version":"3.41.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009169","name":"Assiut University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009169","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Long term use of Flunixin meglumine produces many gastric and hepatic hazards. The current study aimed to investigate using Alpha lipoic acid (ALA) for treating flunixin meglumine (FM)-induced liver and gastrointestinal problems in male rats. FM alternated with ALA for 14 and 56\u00a0days in the experiment. This study divided 72 male rats into six groups, 12 rats for each group. Group 1 (control) received saline and distilled water, Group 2 (ALA) received alpha lipoic acid orally at 100\u00a0mg\/kg bwt, Group 3 (FM-2.5) received Flunixin meglumine subcutaneously at 2.5\u00a0mg\/kg bwt, Group 4 (FM-5) received Flunixin meglumine subcutaneously, Group 5 (FM-2.5 and ALA) received FM and ALA, and Group 6 received FM and ALA. Elevated white blood cell (WBC) concentrations, ALT, AST, ALP, pro-inflammatory cytokines (NF-\u03baB, TNF-\u03b1, HMG), malonaldehyde (MDA), and significant reductions in hepatic and gastric total antioxidant capacity (TAC) were observed. At weeks 4 and 8, FM-5-treated groups had a lower stomach index weight. These changes improved when Groups 5 and 6 used ALA and FM. ALA treatment reduced WBCs, ALT, AST, ALP, NF-\u03baB, TNF-\u03b1, HMG, MDA, TAC, and stomach index weight gains in FM-5-treated groups. Finally, biochemical markers and stomach index volume showed liver and stomach dysfunctions in male rats after FM injections. The simultaneous administration of ALA greatly reduced these deficits, suggesting it may prevent FM-related hepatic and gastrointestinal diseases.\n<\/jats:p>","DOI":"10.1186\/s12917-025-04751-7","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T02:46:59Z","timestamp":1748400419000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mitigation of hepatic and gastric impairments induced by flunixin meglumine through co-administration with alpha lipoic acid in male rats"],"prefix":"10.1186","volume":"21","author":[{"given":"Zeynab Kh.","family":"El-Maddawy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdel-wahed A.","family":"Mashalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sulaiman Mohammed","family":"Alnasser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abd El-Salam F.","family":"El-Sawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walied","family":"Abdo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maher A.","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meshal","family":"Alotaibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8646-5645","authenticated-orcid":false,"given":"Mohsen A.","family":"Khormi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9357-7237","authenticated-orcid":false,"given":"Ali M.","family":"Aborasain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2547-0709","authenticated-orcid":false,"given":"Hanan H.","family":"Abd-El-Hafeez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amal A.","family":"Awad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,28]]},"reference":[{"key":"4751_CR1","first-page":"97","volume":"46","author":"DF Kohn","year":"2007","unstructured":"Kohn DF, et al. Guidelines for the assessment and management of pain in rodents and rabbits. J Am Assoc Lab Anim Sci. 2007;46:97\u2013108.","journal-title":"J Am Assoc Lab Anim Sci"},{"key":"4751_CR2","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1177\/0091270003256061","volume":"43","author":"AT Harder","year":"2003","unstructured":"Harder AT, An YH. The mechanisms of the inhibitory effects of nonsteroidal anti-inflammatory drugs on bone healing: a concise review. J Clin Pharmacol. 2003;43:807\u201315.","journal-title":"J Clin Pharmacol"},{"doi-asserted-by":"crossref","unstructured":"Flecknell P, et al. in Laboratory animal medicine 1135\u20131200 (Elsevier, 2015)Academic Press. Third Edition \u2022ISBN 978-0-12-409527-4.","key":"4751_CR3","DOI":"10.1016\/B978-0-12-409527-4.00024-9"},{"unstructured":"Subhahar, M. Pharmacokinetics and pharmacodynamics of some NSAIDs in horses: A pharmacological, biochemical and forensic study, University of Central Lancashire, (2013). PhD Thesis. University of Central Lancashire.\u200f","key":"4751_CR4"},{"key":"4751_CR5","volume":"3","author":"L Inger","year":"2010","unstructured":"Inger L, Meek I, Mart A, Harald E. Non-steroidal anti-inflammatory drugs: an overview of cardiovascular risks. Pharmaceuticals. 2010;3: e2162.","journal-title":"Pharmaceuticals"},{"key":"4751_CR6","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/j.1439-0442.2007.00959.x","volume":"54","author":"E Yazar","year":"2007","unstructured":"Yazar E, Er A, Uney K, Altunok V, Elmas M. Effect of flunixin meglumine on cytokine levels in experimental endotoxemia in mice. J Vet Med Ser A. 2007;54:352\u20135.","journal-title":"J Vet Med Ser A"},{"key":"4751_CR7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1515\/acve-2016-0008","volume":"66","author":"M Milovanovi\u0107","year":"2016","unstructured":"Milovanovi\u0107 M, Vu\u010dkovi\u0107 S, Prostran M, Trailovi\u0107 S, Jovanovi\u0107 M. L-arginine-NO system participates in the analgesic effect of flunixin meglumine in the rat. Acta Vet. 2016;66:103\u201314.","journal-title":"Acta Vet"},{"key":"4751_CR8","first-page":"53","volume":"10","author":"S Jarolmasjed","year":"2015","unstructured":"Jarolmasjed S, Shahbazfar A-A, Mohammadpour H. Histpathological Anti-inflammatory Effects of Flunixin Meglumine and Ketoprofen on Excised Rat Tendon. Iranian Journal of Veterinary Surgery. 2015;10:53\u20138.","journal-title":"Iranian Journal of Veterinary Surgery"},{"key":"4751_CR9","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1073\/pnas.1517642113","volume":"113","author":"NS Kirkby","year":"2016","unstructured":"Kirkby NS, et al. Systematic study of constitutive cyclooxygenase-2 expression: Role of NF-\u03baB and NFAT transcriptional pathways. Proc Natl Acad Sci. 2016;113:434\u20139.","journal-title":"Proc Natl Acad Sci"},{"key":"4751_CR10","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.2460\/ajvr.1990.51.07.1131","volume":"51","author":"S Dow","year":"1990","unstructured":"Dow S, Rosychuk R, McChesney A, Curtis C. Effects of flunixin and flunixin plus prednisone on the gastrointestinal tract of dogs. Am J Vet Res. 1990;51:1131\u20138.","journal-title":"Am J Vet Res"},{"doi-asserted-by":"crossref","unstructured":"Elwood C, Boswood A, Simpson K, Carmichael S. Renal failure after flunixin meglumine administration. Veterinary Record (United Kingdom) (1992).","key":"4751_CR11","DOI":"10.1136\/vr.130.26.582-a"},{"key":"4751_CR12","first-page":"766","volume":"31","author":"KA Mathews","year":"1990","unstructured":"Mathews KA, Doherty T, Dyson DH, Wilcock B, Valliant A. Nephrotoxicity in dogs associated with methoxyflurane anesthesia and flunixin meglumine analgesia. Can Vet J. 1990;31:766.","journal-title":"Can Vet J"},{"key":"4751_CR13","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0014-5793(91)81164-4","volume":"293","author":"K Fujiwara","year":"1991","unstructured":"Fujiwara K, Okamura-Ikeda K, Motokawa Y. Lipoylation of H-protein of the glycine cleavage system the effect of site-directed mutagenesis of amino acid residues around the lipoyllysine residue on the lipoate attachment. FEBS Lett. 1991;293:115\u20138.","journal-title":"FEBS Lett"},{"key":"4751_CR14","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/0028-3908(95)00172-7","volume":"35","author":"P Wolz","year":"1996","unstructured":"Wolz P, Krieglstein J. Neuroprotective effects of \u03b1-lipoic acid and its enantiomers demonstrated in rodent models of focal cerebral ischemia. Neuropharmacology. 1996;35:369\u201375.","journal-title":"Neuropharmacology"},{"key":"4751_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2840-11-73","volume":"11","author":"C-J Li","year":"2012","unstructured":"Li C-J, Lv L, Li H, Yu D-M. Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid. Cardiovasc Diabetol. 2012;11:1\u201310.","journal-title":"Cardiovasc Diabetol"},{"key":"4751_CR16","first-page":"90","volume":"6","author":"L Wang","year":"2013","unstructured":"Wang L, et al. The protective effect of \u03b1-Lipoic acid on mitochondria in the kidney of diabetic rats. Int J Clin Exp Med. 2013;6:90.","journal-title":"Int J Clin Exp Med"},{"key":"4751_CR17","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/j.1749-6632.2010.05555.x","volume":"1203","author":"L Li","year":"2010","unstructured":"Li L, Smith A, Hagen TM, Frei B. Vascular oxidative stress and inflammation increase with age: ameliorating effects of \u03b1-lipoic acid supplementation. Ann N Y Acad Sci. 2010;1203:151\u20139.","journal-title":"Ann N Y Acad Sci"},{"key":"4751_CR18","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.exger.2011.04.004","volume":"46","author":"A Palaniyappan","year":"2011","unstructured":"Palaniyappan A, Alphonse R. Immunomodulatory effect of DL-\u03b1-lipoic acid in aged rats. Exp Gerontol. 2011;46:709\u201315.","journal-title":"Exp Gerontol"},{"key":"4751_CR19","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1016\/j.fct.2010.04.026","volume":"48","author":"EI Saad","year":"2010","unstructured":"Saad EI, El-Gowilly SM, Sherhaa MO, Bistawroos AE. Role of oxidative stress and nitric oxide in the protective effects of \u03b1-lipoic acid and aminoguanidine against isoniazid\u2013rifampicin-induced hepatotoxicity in rats. Food Chem Toxicol. 2010;48:1869\u201375.","journal-title":"Food Chem Toxicol"},{"key":"4751_CR20","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S1734-1140(11)70600-4","volume":"63","author":"A Gor\u0105ca","year":"2011","unstructured":"Gor\u0105ca A, et al. Lipoic acid-biological activity and therapeutic potential. Pharmacol Rep. 2011;63:849\u201358.","journal-title":"Pharmacol Rep"},{"key":"4751_CR21","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3164\/jcbn.11-005FR","volume":"48","author":"L Packer","year":"2010","unstructured":"Packer L, Cadenas E. Lipoic acid: energy metabolism and redox regulation of transcription and cell signaling. Journal of clinical biochemistry and nutrition. 2010;48:26\u201332.","journal-title":"Journal of clinical biochemistry and nutrition"},{"key":"4751_CR22","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jdiacomp.2010.07.004","volume":"25","author":"X Yi","year":"2011","unstructured":"Yi X, Nickeleit V, James LR, Maeda N. \u03b1-Lipoic acid protects diabetic apolipoprotein E-deficient mice from nephropathy. J Diabetes Complications. 2011;25:193\u2013201.","journal-title":"J Diabetes Complications"},{"key":"4751_CR23","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s10792-014-0029-3","volume":"35","author":"E Kan","year":"2015","unstructured":"Kan E, Kili\u00e7kan E, Ayar A, \u00c7olak R. Effects of two antioxidants; \u03b1-lipoic acid and fisetin against diabetic cataract in mice. Int Ophthalmol. 2015;35:115\u201320.","journal-title":"Int Ophthalmol"},{"doi-asserted-by":"crossref","unstructured":"Du Sert NP et al. Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0. PLoS biology 18, e3000411 (2020).","key":"4751_CR24","DOI":"10.1371\/journal.pbio.3000411"},{"key":"4751_CR25","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1177\/0960327116674526","volume":"36","author":"A Khalaf","year":"2017","unstructured":"Khalaf A, et al. The potential protective effect of \u03b1-lipoic acid against nanocopper particle\u2013induced hepatotoxicity in male rats. Hum Exp Toxicol. 2017;36:881\u201391.","journal-title":"Hum Exp Toxicol"},{"key":"4751_CR26","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/jat.940","volume":"24","author":"L Pari","year":"2004","unstructured":"Pari L, Murugavel P. Protective effect of \u03b1-lipoic acid against chloroquine-induced hepatotoxicity in rats. Journal of Applied Toxicology: An International Journal. 2004;24:21\u20136.","journal-title":"Journal of Applied Toxicology: An International Journal"},{"key":"4751_CR27","first-page":"185","volume":"50","author":"JT Tubbs","year":"2011","unstructured":"Tubbs JT, et al. Effects of buprenorphine, meloxicam, and flunixin meglumine as postoperative analgesia in mice. J Am Assoc Lab Anim Sci. 2011;50:185\u201391.","journal-title":"J Am Assoc Lab Anim Sci"},{"key":"4751_CR28","first-page":"185","volume":"157","author":"S Erpek","year":"2006","unstructured":"Erpek S, Kilic N, Kozaci D, Dikicioglu E, Kavak T. Effects of flunixin meglumine, diclofenac sodium and metamizole sodium on experimental wound healing in rats. Revue de m\u00e9decine v\u00e9t\u00e9rinaire. 2006;157:185.","journal-title":"Revue de m\u00e9decine v\u00e9t\u00e9rinaire"},{"doi-asserted-by":"crossref","unstructured":"Paksoy Z, KIRBA\u015e, A. Evaluation of the contraceptive effects of carprofen, flunixin meglumine and meloxicam in rats. Veterin\u00e1rn\u00ed medic\u00edna. 2017;62(05):274\u20138.","key":"4751_CR29","DOI":"10.17221\/67\/2016-VETMED"},{"key":"4751_CR30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1530\/jrf.0.0190063","volume":"19","author":"J Matousek","year":"1969","unstructured":"Matousek J. Effects on spermatogenesis in guinea-pigs, rabbits and sheep after their immunization with sexual organ fluids of bulls. Reproduction. 1969;19:63\u201372.","journal-title":"Reproduction"},{"doi-asserted-by":"crossref","unstructured":"Lowry OH, Rosebrough NJ, Farr AL & RJ., R. Protein measurements with Folin- phenol reagent. J Biol Chem 70, 193: 265 (1951).","key":"4751_CR31","DOI":"10.1016\/S0021-9258(19)52451-6"},{"key":"4751_CR32","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1126\/science.1062374","volume":"293","author":"L-F Chen","year":"2001","unstructured":"Chen L-F, Fischle W, Verdin E, Greene WC. Duration of nuclear NF-\u03baB action regulated by reversible acetylation. Science. 2001;293:1653\u20137.","journal-title":"Science"},{"key":"4751_CR33","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/0092-8674(91)90320-X","volume":"64","author":"GP Nolan","year":"1991","unstructured":"Nolan GP, Ghosh S, Liou H-C, Tempst P, Baltimore D. DNA binding and I\u03baB inhibition of the cloned p65 subunit of NF-\u03baB, a rel-related polypeptide. Cell. 1991;64:961\u20139.","journal-title":"Cell"},{"doi-asserted-by":"crossref","unstructured":"Old L. Tumor Necrosis Factor (TNF) Science. 1985;230(4726).","key":"4751_CR34","DOI":"10.1126\/science.2413547"},{"key":"4751_CR35","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","volume":"67","author":"Y Dowlati","year":"2010","unstructured":"Dowlati Y, et al. A meta-analysis of cytokines in major depression. Biol Psychiat. 2010;67:446\u201357.","journal-title":"Biol Psychiat"},{"key":"4751_CR36","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1136\/gut.51.1.37","volume":"51","author":"J Brynskov","year":"2002","unstructured":"Brynskov J, et al. Tumour necrosis factor \u03b1 converting enzyme (TACE) activity in the colonic mucosa of patients with inflammatory bowel disease. Gut. 2002;51:37\u201343.","journal-title":"Gut"},{"key":"4751_CR37","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1006\/geno.1996.0369","volume":"35","author":"S Ferrari","year":"1996","unstructured":"Ferrari S, Finelli P, Rocchi M, Bianchi M. The active gene that encodes human high mobility group 1 protein (HMG1) contains introns and maps to chromosome 13. Genomics. 1996;35:367\u201371.","journal-title":"Genomics"},{"key":"4751_CR38","first-page":"120","volume":"77","author":"DK Chou","year":"2001","unstructured":"Chou DK, Evans JE, Jungalwala FB. Identity of nuclear high-mobility-group protein, HMG-1, and sulfoglucuronyl carbohydrate-binding protein, SBP-1, in brain. J Neurochem. 2001;77:120\u201331.","journal-title":"J Neurochem"},{"key":"4751_CR39","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.gde.2005.08.007","volume":"15","author":"ME Bianchi","year":"2005","unstructured":"Bianchi ME, Agresti A. HMG proteins: dynamic players in gene regulation and differentiation. Curr Opin Genet Dev. 2005;15:496\u2013506.","journal-title":"Curr Opin Genet Dev"},{"key":"4751_CR40","doi-asserted-by":"publisher","first-page":"357","DOI":"10.2119\/molmed.2013.00099","volume":"19","author":"R Chen","year":"2013","unstructured":"Chen R, et al. Emerging role of high-mobility group box 1 (HMGB1) in liver diseases. Mol Med. 2013;19:357\u201366.","journal-title":"Mol Med"},{"key":"4751_CR41","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1085\/jgp.16.1.59","volume":"16","author":"M Anson","year":"1932","unstructured":"Anson M, Mirsky A. The estimation of pepsin with hemoglobin. J Gen Physiol. 1932;16:59.","journal-title":"J Gen Physiol"},{"key":"4751_CR42","first-page":"116","volume":"242","author":"S Corne","year":"1974","unstructured":"Corne S. A method for the quantitive estimation of gastric barrier mucus. J Physiol (London). 1974;242:116\u20137.","journal-title":"J Physiol (London)"},{"key":"4751_CR43","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","volume":"95","author":"H Ohkawa","year":"1979","unstructured":"Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95:351\u20138.","journal-title":"Anal Biochem"},{"key":"4751_CR44","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1136\/jcp.54.5.356","volume":"54","author":"D Koracevic","year":"2001","unstructured":"Koracevic D, Koracevic G, Djordjevic V, Andrejevic S, Cosic V. Method for the measurement of antioxidant activity in human fluids. J Clin Pathol. 2001;54:356\u201361.","journal-title":"J Clin Pathol"},{"key":"4751_CR45","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cbi.2013.11.011","volume":"208","author":"W-F Li","year":"2014","unstructured":"Li W-F, et al. Protective effect of chelerythrine against ethanol-induced gastric ulcer in mice. Chem Biol Interact. 2014;208:18\u201327.","journal-title":"Chem Biol Interact"},{"key":"4751_CR46","volume-title":"(Oxford Univ","author":"M Harries","year":"1989","unstructured":"Harries M. (Oxford Univ. New York, Toronto: Press; 1989."},{"unstructured":"Steel RGD, Torrie JH. Principles and procedures of statistics, a biometrical approach. 2d ed.\u00a0Publisher McGraw-HillMcGraw-Hill Kogakusha, Ltd.;\u00a01980. p. 633.","key":"4751_CR47"},{"key":"4751_CR48","doi-asserted-by":"publisher","first-page":"211","DOI":"10.2460\/ajvr.2003.64.211","volume":"64","author":"CE Bryant","year":"2003","unstructured":"Bryant CE, Farnfield BA, Janicke HJ. Evaluation of the ability of carprofen and flunixin meglumine to inhibit activation of nuclear factor kappa B. Am J Vet Res. 2003;64:211\u20135.","journal-title":"Am J Vet Res"},{"key":"4751_CR49","first-page":"1","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun S-C. NF-\u03baB signaling in inflammation. Signal Transduct Target Ther. 2017;2:1\u20139.","journal-title":"Signal Transduct Target Ther"},{"key":"4751_CR50","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nri.2017.142","volume":"18","author":"K Taniguchi","year":"2018","unstructured":"Taniguchi K, Karin M. NF-\u03baB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018;18:309\u201324.","journal-title":"Nat Rev Immunol"},{"key":"4751_CR51","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/bs.ircmb.2017.07.007","volume":"335","author":"JP Mitchell","year":"2018","unstructured":"Mitchell JP, Carmody RJ. NF-\u03baB and the transcriptional control of inflammation. Int Rev Cell Mol Biol. 2018;335:41\u201384.","journal-title":"Int Rev Cell Mol Biol"},{"key":"4751_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2020.152536","volume":"442","author":"RS Said","year":"2020","unstructured":"Said RS, Mohamed HA, Kassem DH. Alpha-lipoic acid effectively attenuates ionizing radiation-mediated testicular dysfunction in rats: Crosstalk of NF-\u0138B, TGF-\u03b2, and PPAR-\u03d2 pathways. Toxicology. 2020;442: 152536.","journal-title":"Toxicology"},{"key":"4751_CR53","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s00011-010-0256-7","volume":"60","author":"Z Ying","year":"2011","unstructured":"Ying Z, Kampfrath T, Sun Q, Parthasarathy S, Rajagopalan S. Evidence that \u03b1-lipoic acid inhibits NF-\u03baB activation independent of its antioxidant function. Inflamm Res. 2011;60:219\u201325.","journal-title":"Inflamm Res"},{"key":"4751_CR54","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s00011-017-1079-6","volume":"66","author":"D Tibullo","year":"2017","unstructured":"Tibullo D, et al. Biochemical and clinical relevance of alpha lipoic acid: antioxidant and anti-inflammatory activity, molecular pathways and therapeutic potential. Inflamm Res. 2017;66:947\u201359.","journal-title":"Inflamm Res"},{"key":"4751_CR55","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.sjbs.2012.01.005","volume":"19","author":"SM Prabu","year":"2012","unstructured":"Prabu SM, Muthumani M, Shagirtha K. Protective effect of Piper betle leaf extract against cadmium-induced oxidative stress and hepatic dysfunction in rats. Saudi journal of biological sciences. 2012;19:229\u201339.","journal-title":"Saudi journal of biological sciences"},{"key":"4751_CR56","doi-asserted-by":"publisher","first-page":"367","DOI":"10.33899\/ijvs.2021.130323.1800","volume":"36","author":"IA Mohammed","year":"2022","unstructured":"Mohammed IA, Shaban KA, Albadrany YM. Hepato-renal and hematological effects of flunixin and silymarin coadministration in rats. Iraqi Journal of Veterinary Sciences. 2022;36:367\u201373.","journal-title":"Iraqi Journal of Veterinary Sciences"},{"key":"4751_CR57","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1093\/qjmed\/hcg138","volume":"96","author":"N O'connor","year":"2003","unstructured":"O\u2019connor N, Dargan PI, Jones AL. Hepatocellular damage from non-steroidal anti-inflammatory drugs. QJM. 2003;96:787\u201391.","journal-title":"QJM"},{"key":"4751_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174201","volume":"906","author":"F Yaqub","year":"2021","unstructured":"Yaqub F, Latief N, Butt H, Naseer N, Riazuddin S. Alpha lipoic acid priming enhances the hepatoprotective effect of adipose derived stem cells in CCl4 induced hepatic injury in-vitro. Eur J Pharmacol. 2021;906: 174201.","journal-title":"Eur J Pharmacol"},{"unstructured":"Morakinyo A, Oludare G, Anifowose A, Adegoke O. Protective effects of alpha lipoic acid on carbon tetrachloride-induced liver and kidney damage in rats. Br J Pharmacol Toxicol.\u00a02012;3(1):21\u20138.","key":"4751_CR59"},{"doi-asserted-by":"publisher","unstructured":"Kaya-Dagistanli F, Tanr\u0131verdi G, Alt\u0131nok A, Ozyazgan S, Ozturk M. The effects of alpha lipoic acid on damaged liver cells induced by n-6 polyunsaturated fatty acids in the young rats.Food Chem Toxicol. 2013;53:84-93. https:\/\/doi.org\/10.1016\/j.fct.2012.11.026. Epub 2012 Nov 29. PMID: 23200892.","key":"4751_CR60","DOI":"10.1016\/j.fct.2012.11.026"},{"key":"4751_CR61","doi-asserted-by":"publisher","first-page":"258","DOI":"10.2460\/ajvr.68.3.258","volume":"68","author":"SP Luna","year":"2007","unstructured":"Luna SP, et al. Evaluation of adverse effects of long-term oral administration of carprofen, etodolac, flunixin meglumine, ketoprofen, and meloxicam in dogs. Am J Vet Res. 2007;68:258\u201364.","journal-title":"Am J Vet Res"},{"key":"4751_CR62","first-page":"694","volume":"8","author":"MA Hamzawy","year":"2014","unstructured":"Hamzawy MA, et al. Hepatoprotective effect of estradiol and-Lipoic Acid in Rats. Global Journal of Pharmacology. 2014;8:694\u2013702.","journal-title":"Global Journal of Pharmacology"},{"key":"4751_CR63","first-page":"9","volume":"46","author":"S Yakan","year":"2018","unstructured":"Yakan S, Duzguner V, Aksoy O. Effects of flunixin meglumine on oxidant and antioxidant system after disbudding with caustic paste in calves. Acta Sci Vet. 2018;46:9\u20139.","journal-title":"Acta Sci Vet"},{"key":"4751_CR64","first-page":"11","volume":"13","author":"AT Ellethy","year":"2019","unstructured":"Ellethy AT. Potential antitumor activity of nonsteroidal anti-inflammatory drugs against Ehrlich ascites carcinoma in experimental animals. Int J Health Sci. 2019;13:11.","journal-title":"Int J Health Sci"},{"key":"4751_CR65","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0009-8981(02)00300-5","volume":"326","author":"K Kolanjiappan","year":"2002","unstructured":"Kolanjiappan K, Manoharan S, Kayalvizhi M. Measurement of erythrocyte lipids, lipid peroxidation, antioxidants and osmotic fragility in cervical cancer patients. Clin Chim Acta. 2002;326:143\u20139.","journal-title":"Clin Chim Acta"},{"key":"4751_CR66","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/biof.5520170120","volume":"17","author":"A Bast","year":"2003","unstructured":"Bast A, Haenen GR. Lipoic acid: a multifunctional antioxidant. BioFactors. 2003;17:207\u201313.","journal-title":"BioFactors"},{"key":"4751_CR67","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.addr.2008.04.015","volume":"60","author":"A Maczurek","year":"2008","unstructured":"Maczurek A, et al. Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer\u2019s disease. Adv Drug Deliv Rev. 2008;60:1463\u201370.","journal-title":"Adv Drug Deliv Rev"},{"key":"4751_CR68","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0306-3623(96)00474-0","volume":"29","author":"GP Biewenga","year":"1997","unstructured":"Biewenga GP, Haenen GR, Bast A. The pharmacology of the antioxidant lipoic acid. General Pharmacology: The Vascular System. 1997;29:315\u201331.","journal-title":"General Pharmacology: The Vascular System"},{"key":"4751_CR69","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.jss.2014.08.057","volume":"193","author":"Y Tanaka","year":"2015","unstructured":"Tanaka Y, et al. Alpha-lipoic acid exerts a liver-protective effect in acute liver injury rats. J Surg Res. 2015;193:675\u201383.","journal-title":"J Surg Res"},{"doi-asserted-by":"crossref","unstructured":"Hawkey C, Langman M. Non-steroidal anti-inflammatory drugs: overall risks and management. Complementary roles for COX-2 inhibitors and proton pump inhibitors. Gut 52, 600 (2003).","key":"4751_CR70","DOI":"10.1136\/gut.52.4.600"},{"doi-asserted-by":"crossref","unstructured":"Hawkins C, Hanks GW. The gastroduodenal toxicity of nonsteroidal anti-inflammatory drugs. A review of the literature. Journal of pain and symptom management 20, 140\u2013151 (2000).","key":"4751_CR71","DOI":"10.1016\/S0885-3924(00)00175-5"},{"key":"4751_CR72","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1159\/000199621","volume":"39","author":"K Ishihara","year":"1988","unstructured":"Ishihara K, Kuwata H, Ohara S, Okabe H, Hotta K. Changes of rat gastric mucus glycoproteins in cytoprotection: influences of prostaglandin derivatives. Digestion. 1988;39:162\u201371.","journal-title":"Digestion"},{"key":"4751_CR73","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.ejphar.2009.02.008","volume":"607","author":"GH Heeba","year":"2009","unstructured":"Heeba GH, Hassan MK, Amin RS. Gastroprotective effect of simvastatin against indomethacin-induced gastric ulcer in rats: role of nitric oxide and prostaglandins. Eur J Pharmacol. 2009;607:188\u201393.","journal-title":"Eur J Pharmacol"},{"unstructured":"Corfield AP. Glycoprotein methods and protocols: The mucins. Vol. 125 (Springer Science & Business Media, 2007).","key":"4751_CR74"},{"key":"4751_CR75","doi-asserted-by":"publisher","first-page":"1131S","DOI":"10.1093\/ajcn\/73.6.1131S","volume":"73","author":"B Deplancke","year":"2001","unstructured":"Deplancke B, Gaskins HR. Microbial modulation of innate defense: goblet cells and the intestinal mucus layer. Am J Clin Nutr. 2001;73:1131S-1141S.","journal-title":"Am J Clin Nutr"},{"key":"4751_CR76","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1111\/j.1440-1746.2007.04840.x","volume":"22","author":"S Santhosh","year":"2007","unstructured":"Santhosh S, Anandan R, Sini TK, Mathew PT. Protective effect of glucosamine against ibuprofen-induced peptic ulcer in rats. J Gastroenterol Hepatol. 2007;22:949\u201353.","journal-title":"J Gastroenterol Hepatol"},{"unstructured":"Marcinkiewicz M, Peura DA, Sarosiek J. The relationship between the content of aggressive and protective components in gastric juice and endoscopic findings after naproxen sodium and acetaminophen administration. American Journal of Gastroenterology (Springer Nature) 91 (1996).","key":"4751_CR77"}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-025-04751-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12917-025-04751-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-025-04751-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T04:06:14Z","timestamp":1748405174000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-025-04751-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,28]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4751"],"URL":"https:\/\/doi.org\/10.1186\/s12917-025-04751-7","relation":{},"ISSN":["1746-6148"],"issn-type":[{"type":"electronic","value":"1746-6148"}],"subject":[],"published":{"date-parts":[[2025,5,28]]},"assertion":[{"value":"14 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study complied with the ARRIVE guidelines and followed the U.K. Animals (Scientific Procedures) Act, 1986, and associated guidelines, EU Directive 2010\/63\/EU for animal experiments.This study followed the rules for the care and use of animals. It was intrinsically approved by the Animal Welfare and Ethics Committee, Faculty of Veterinary Medicine, Alexandria University, and approved by Institutional Animal Care and Use Committee (ALEXU\u2011IACUC).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"382"}}